The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Human Insulin Market Research Report 2024

Global Human Insulin Market Research Report 2024

Publishing Date : Mar, 2024

License Type :
 

Report Code : 1805124

No of Pages : 89

Ask Your Query

Synopsis

Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans.

The global Human Insulin market was valued at US$ 55850 million in 2023 and is anticipated to reach US$ 105620 million by 2030, witnessing a CAGR of 9.4% during the forecast period 2024-2030.

In 2018, North America is estimated to dominate the global human insulin market. The Asia-Pacific market is poised to grow the fastest, during the forecast period, owing to growing diabetes prevalence in APAC (coupled with large diabetic & pre-diabetic patient population), strengthening distribution networks of global product manufacturers in the region, evolving regulatory framework for marketing approvals & medical reimbursements, continued expansion of advanced medical facilities in emerging countries (such as China & India), and rising public awareness related to benefits offered by human insulin in diabetes treatment.

This report aims to provide a comprehensive presentation of the global market for Human Insulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Insulin.

Report Scope

The Human Insulin market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Insulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Insulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • B. Braun
  • Becton, Dickinson
  • Biocon
  • Biodel
  • ELI Lilly
  • Julphar
  • NOVO Nordisk
  • Sanofi
  • Wockhardt
  • Ypsomed

Segment by Type

  • Insulin Analogs and Biosimilars
  • Human Insulin Biologics

Segment by Application

  • Short Acting
  • Intermediate Acting
  • Long Acting
  • Pre-Mix Insulin

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Insulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Insulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Human Insulin Market Overview
1.1 Product Overview and Scope of Human Insulin
1.2 Human Insulin Segment by Type
1.2.1 Global Human Insulin Market Value Comparison by Type (2024-2030)
1.2.2 Insulin Analogs and Biosimilars
1.2.3 Human Insulin Biologics
1.3 Human Insulin Segment by Application
1.3.1 Global Human Insulin Market Value by Application: (2024-2030)
1.3.2 Short Acting
1.3.3 Intermediate Acting
1.3.4 Long Acting
1.3.5 Pre-Mix Insulin
1.4 Global Human Insulin Market Size Estimates and Forecasts
1.4.1 Global Human Insulin Revenue 2019-2030
1.4.2 Global Human Insulin Sales 2019-2030
1.4.3 Global Human Insulin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Insulin Market Competition by Manufacturers
2.1 Global Human Insulin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Insulin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Insulin Average Price by Manufacturers (2019-2024)
2.4 Global Human Insulin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Insulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Insulin, Product Type & Application
2.7 Human Insulin Market Competitive Situation and Trends
2.7.1 Human Insulin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Insulin Players Market Share by Revenue
2.7.3 Global Human Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Insulin Retrospective Market Scenario by Region
3.1 Global Human Insulin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Insulin Global Human Insulin Sales by Region: 2019-2030
3.2.1 Global Human Insulin Sales by Region: 2019-2024
3.2.2 Global Human Insulin Sales by Region: 2025-2030
3.3 Global Human Insulin Global Human Insulin Revenue by Region: 2019-2030
3.3.1 Global Human Insulin Revenue by Region: 2019-2024
3.3.2 Global Human Insulin Revenue by Region: 2025-2030
3.4 North America Human Insulin Market Facts & Figures by Country
3.4.1 North America Human Insulin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Insulin Sales by Country (2019-2030)
3.4.3 North America Human Insulin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Insulin Market Facts & Figures by Country
3.5.1 Europe Human Insulin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Insulin Sales by Country (2019-2030)
3.5.3 Europe Human Insulin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Insulin Market Facts & Figures by Country
3.6.1 Asia Pacific Human Insulin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Insulin Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Insulin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Insulin Market Facts & Figures by Country
3.7.1 Latin America Human Insulin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Insulin Sales by Country (2019-2030)
3.7.3 Latin America Human Insulin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Insulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Insulin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Insulin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Insulin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Insulin Sales by Type (2019-2030)
4.1.1 Global Human Insulin Sales by Type (2019-2024)
4.1.2 Global Human Insulin Sales by Type (2025-2030)
4.1.3 Global Human Insulin Sales Market Share by Type (2019-2030)
4.2 Global Human Insulin Revenue by Type (2019-2030)
4.2.1 Global Human Insulin Revenue by Type (2019-2024)
4.2.2 Global Human Insulin Revenue by Type (2025-2030)
4.2.3 Global Human Insulin Revenue Market Share by Type (2019-2030)
4.3 Global Human Insulin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Insulin Sales by Application (2019-2030)
5.1.1 Global Human Insulin Sales by Application (2019-2024)
5.1.2 Global Human Insulin Sales by Application (2025-2030)
5.1.3 Global Human Insulin Sales Market Share by Application (2019-2030)
5.2 Global Human Insulin Revenue by Application (2019-2030)
5.2.1 Global Human Insulin Revenue by Application (2019-2024)
5.2.2 Global Human Insulin Revenue by Application (2025-2030)
5.2.3 Global Human Insulin Revenue Market Share by Application (2019-2030)
5.3 Global Human Insulin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 B. Braun
6.1.1 B. Braun Corporation Information
6.1.2 B. Braun Description and Business Overview
6.1.3 B. Braun Human Insulin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 B. Braun Human Insulin Product Portfolio
6.1.5 B. Braun Recent Developments/Updates
6.2 Becton, Dickinson
6.2.1 Becton, Dickinson Corporation Information
6.2.2 Becton, Dickinson Description and Business Overview
6.2.3 Becton, Dickinson Human Insulin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Becton, Dickinson Human Insulin Product Portfolio
6.2.5 Becton, Dickinson Recent Developments/Updates
6.3 Biocon
6.3.1 Biocon Corporation Information
6.3.2 Biocon Description and Business Overview
6.3.3 Biocon Human Insulin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Biocon Human Insulin Product Portfolio
6.3.5 Biocon Recent Developments/Updates
6.4 Biodel
6.4.1 Biodel Corporation Information
6.4.2 Biodel Description and Business Overview
6.4.3 Biodel Human Insulin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biodel Human Insulin Product Portfolio
6.4.5 Biodel Recent Developments/Updates
6.5 ELI Lilly
6.5.1 ELI Lilly Corporation Information
6.5.2 ELI Lilly Description and Business Overview
6.5.3 ELI Lilly Human Insulin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 ELI Lilly Human Insulin Product Portfolio
6.5.5 ELI Lilly Recent Developments/Updates
6.6 Julphar
6.6.1 Julphar Corporation Information
6.6.2 Julphar Description and Business Overview
6.6.3 Julphar Human Insulin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Julphar Human Insulin Product Portfolio
6.6.5 Julphar Recent Developments/Updates
6.7 NOVO Nordisk
6.6.1 NOVO Nordisk Corporation Information
6.6.2 NOVO Nordisk Description and Business Overview
6.6.3 NOVO Nordisk Human Insulin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 NOVO Nordisk Human Insulin Product Portfolio
6.7.5 NOVO Nordisk Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Human Insulin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sanofi Human Insulin Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Wockhardt
6.9.1 Wockhardt Corporation Information
6.9.2 Wockhardt Description and Business Overview
6.9.3 Wockhardt Human Insulin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Wockhardt Human Insulin Product Portfolio
6.9.5 Wockhardt Recent Developments/Updates
6.10 Ypsomed
6.10.1 Ypsomed Corporation Information
6.10.2 Ypsomed Description and Business Overview
6.10.3 Ypsomed Human Insulin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Ypsomed Human Insulin Product Portfolio
6.10.5 Ypsomed Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Insulin Industry Chain Analysis
7.2 Human Insulin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Insulin Production Mode & Process
7.4 Human Insulin Sales and Marketing
7.4.1 Human Insulin Sales Channels
7.4.2 Human Insulin Distributors
7.5 Human Insulin Customers
8 Human Insulin Market Dynamics
8.1 Human Insulin Industry Trends
8.2 Human Insulin Market Drivers
8.3 Human Insulin Market Challenges
8.4 Human Insulin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Human Insulin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Human Insulin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Human Insulin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Human Insulin Sales (K Doses) of Key Manufacturers (2019-2024)
Table 5. Global Human Insulin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Human Insulin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Human Insulin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Human Insulin Average Price (USD/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Human Insulin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human Insulin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Insulin, Product Type & Application
Table 12. Global Key Manufacturers of Human Insulin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Insulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Insulin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Insulin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Human Insulin Sales by Region (2019-2024) & (K Doses)
Table 18. Global Human Insulin Sales Market Share by Region (2019-2024)
Table 19. Global Human Insulin Sales by Region (2025-2030) & (K Doses)
Table 20. Global Human Insulin Sales Market Share by Region (2025-2030)
Table 21. Global Human Insulin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Human Insulin Revenue Market Share by Region (2019-2024)
Table 23. Global Human Insulin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Human Insulin Revenue Market Share by Region (2025-2030)
Table 25. North America Human Insulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Human Insulin Sales by Country (2019-2024) & (K Doses)
Table 27. North America Human Insulin Sales by Country (2025-2030) & (K Doses)
Table 28. North America Human Insulin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Human Insulin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Human Insulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Human Insulin Sales by Country (2019-2024) & (K Doses)
Table 32. Europe Human Insulin Sales by Country (2025-2030) & (K Doses)
Table 33. Europe Human Insulin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Human Insulin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Human Insulin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Human Insulin Sales by Region (2019-2024) & (K Doses)
Table 37. Asia Pacific Human Insulin Sales by Region (2025-2030) & (K Doses)
Table 38. Asia Pacific Human Insulin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Human Insulin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Human Insulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Human Insulin Sales by Country (2019-2024) & (K Doses)
Table 42. Latin America Human Insulin Sales by Country (2025-2030) & (K Doses)
Table 43. Latin America Human Insulin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Human Insulin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Human Insulin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Human Insulin Sales by Country (2019-2024) & (K Doses)
Table 47. Middle East & Africa Human Insulin Sales by Country (2025-2030) & (K Doses)
Table 48. Middle East & Africa Human Insulin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Human Insulin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Human Insulin Sales (K Doses) by Type (2019-2024)
Table 51. Global Human Insulin Sales (K Doses) by Type (2025-2030)
Table 52. Global Human Insulin Sales Market Share by Type (2019-2024)
Table 53. Global Human Insulin Sales Market Share by Type (2025-2030)
Table 54. Global Human Insulin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Human Insulin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Human Insulin Revenue Market Share by Type (2019-2024)
Table 57. Global Human Insulin Revenue Market Share by Type (2025-2030)
Table 58. Global Human Insulin Price (USD/Dose) by Type (2019-2024)
Table 59. Global Human Insulin Price (USD/Dose) by Type (2025-2030)
Table 60. Global Human Insulin Sales (K Doses) by Application (2019-2024)
Table 61. Global Human Insulin Sales (K Doses) by Application (2025-2030)
Table 62. Global Human Insulin Sales Market Share by Application (2019-2024)
Table 63. Global Human Insulin Sales Market Share by Application (2025-2030)
Table 64. Global Human Insulin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Human Insulin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Human Insulin Revenue Market Share by Application (2019-2024)
Table 67. Global Human Insulin Revenue Market Share by Application (2025-2030)
Table 68. Global Human Insulin Price (USD/Dose) by Application (2019-2024)
Table 69. Global Human Insulin Price (USD/Dose) by Application (2025-2030)
Table 70. B. Braun Corporation Information
Table 71. B. Braun Description and Business Overview
Table 72. B. Braun Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 73. B. Braun Human Insulin Product
Table 74. B. Braun Recent Developments/Updates
Table 75. Becton, Dickinson Corporation Information
Table 76. Becton, Dickinson Description and Business Overview
Table 77. Becton, Dickinson Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 78. Becton, Dickinson Human Insulin Product
Table 79. Becton, Dickinson Recent Developments/Updates
Table 80. Biocon Corporation Information
Table 81. Biocon Description and Business Overview
Table 82. Biocon Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 83. Biocon Human Insulin Product
Table 84. Biocon Recent Developments/Updates
Table 85. Biodel Corporation Information
Table 86. Biodel Description and Business Overview
Table 87. Biodel Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 88. Biodel Human Insulin Product
Table 89. Biodel Recent Developments/Updates
Table 90. ELI Lilly Corporation Information
Table 91. ELI Lilly Description and Business Overview
Table 92. ELI Lilly Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 93. ELI Lilly Human Insulin Product
Table 94. ELI Lilly Recent Developments/Updates
Table 95. Julphar Corporation Information
Table 96. Julphar Description and Business Overview
Table 97. Julphar Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 98. Julphar Human Insulin Product
Table 99. Julphar Recent Developments/Updates
Table 100. NOVO Nordisk Corporation Information
Table 101. NOVO Nordisk Description and Business Overview
Table 102. NOVO Nordisk Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 103. NOVO Nordisk Human Insulin Product
Table 104. NOVO Nordisk Recent Developments/Updates
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 108. Sanofi Human Insulin Product
Table 109. Sanofi Recent Developments/Updates
Table 110. Wockhardt Corporation Information
Table 111. Wockhardt Description and Business Overview
Table 112. Wockhardt Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 113. Wockhardt Human Insulin Product
Table 114. Wockhardt Recent Developments/Updates
Table 115. Ypsomed Corporation Information
Table 116. Ypsomed Description and Business Overview
Table 117. Ypsomed Human Insulin Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 118. Ypsomed Human Insulin Product
Table 119. Ypsomed Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Human Insulin Distributors List
Table 123. Human Insulin Customers List
Table 124. Human Insulin Market Trends
Table 125. Human Insulin Market Drivers
Table 126. Human Insulin Market Challenges
Table 127. Human Insulin Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Insulin
Figure 2. Global Human Insulin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Human Insulin Market Share by Type in 2023 & 2030
Figure 4. Insulin Analogs and Biosimilars Product Picture
Figure 5. Human Insulin Biologics Product Picture
Figure 6. Global Human Insulin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Human Insulin Market Share by Application in 2023 & 2030
Figure 8. Short Acting
Figure 9. Intermediate Acting
Figure 10. Long Acting
Figure 11. Pre-Mix Insulin
Figure 12. Global Human Insulin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Human Insulin Market Size (2019-2030) & (US$ Million)
Figure 14. Global Human Insulin Sales (2019-2030) & (K Doses)
Figure 15. Global Human Insulin Average Price (USD/Dose) & (2019-2030)
Figure 16. Human Insulin Report Years Considered
Figure 17. Human Insulin Sales Share by Manufacturers in 2023
Figure 18. Global Human Insulin Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Human Insulin Players: Market Share by Revenue in 2023
Figure 20. Human Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Human Insulin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Human Insulin Sales Market Share by Country (2019-2030)
Figure 23. North America Human Insulin Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Human Insulin Sales Market Share by Country (2019-2030)
Figure 27. Europe Human Insulin Revenue Market Share by Country (2019-2030)
Figure 28. Germany Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Human Insulin Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Human Insulin Revenue Market Share by Region (2019-2030)
Figure 35. China Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Human Insulin Sales Market Share by Country (2019-2030)
Figure 46. Latin America Human Insulin Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Human Insulin Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Human Insulin Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Human Insulin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Human Insulin by Type (2019-2030)
Figure 56. Global Revenue Market Share of Human Insulin by Type (2019-2030)
Figure 57. Global Human Insulin Price (USD/Dose) by Type (2019-2030)
Figure 58. Global Sales Market Share of Human Insulin by Application (2019-2030)
Figure 59. Global Revenue Market Share of Human Insulin by Application (2019-2030)
Figure 60. Global Human Insulin Price (USD/Dose) by Application (2019-2030)
Figure 61. Human Insulin Value Chain
Figure 62. Human Insulin Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock